NPPB and heart failure: Of 23 patients who met the primary endpoint in the withdrawal group, 9 fulfilled more than one criterion for relapse (23%), 9 patients (23%) met the LVESVi criterion, 6 (15%) met the NT-proBNP criterion, and 17 (42.5%) had clinical evidence of heart failure (Figure 3B).